Michael Cannon-Brookes, CEO, Co-Founder, and 10% owner of Atlassian Corp, reported the disposition of 5625 Class A Common Stock shares on December 19, 2025. The transactions were executed under a Rule 10b5-1 trading plan at prices ranging from $160.76 to $165.59, with a weighted-average price of $161.33 for the first t...

Michael Cannon-Brookes, CEO, Co-Founder, and 10% owner of Atlassian Corp, reported a series of dispositions of Class A Common Stock on December 22, 2025. These transactions were executed under a Rule 10b5-1 trading plan. A total of 8665 shares were sold across multiple trades at prices ranging from $161.44 to $165.46. ...

On December 23, 2025, Michael Cannon-Brookes, CEO, Co-Founder, and 10% owner of Atlassian Corp, reported the sale of 8,270 shares of Class A Common Stock through a Rule 10b5-1 trading plan. The sales occurred at prices ranging from $158.53 to $163.42, with a weighted-average price of approximately $161.37. These transa...

On December 19, 2025, Scott Farquhar, a 10% owner and director of Atlassian Corp, reported the sale of 5625.0 shares of Class A Common Stock through a Rule 10b5-1 trading plan. The transactions were executed at prices ranging from $160.76 to $164.71, with a weighted-average price of approximately $162.67. These sales r...

Scott Farquhar, a 10% owner and director of Atlassian Corp, reported the sale of 5599 shares of Class A Common Stock on December 22, 2025. The sales were executed under a Rule 10b5-1 trading plan at prices ranging from $161.44 to $165.68, with a weighted-average price of $164.1867. The total number of shares sold was 7...

On December 23, 2025, Scott Farquhar, a 10% owner and director of Atlassian Corp, reported the disposition of 7967 shares of Class A Common Stock. These transactions were executed under a Rule 10b5-1 trading plan at prices ranging from $158.53 to $163.42, with a weighted-average price. The shares were held indirectly t...

This filing details transactions of Class A Common Stock by GENE LIU, Chief Accounting Officer of Atlassian Corp. On December 20, 2025, Mr. Liu acquired 3,257 shares under a restricted stock unit award, with a transaction price of $0.00 per share. This award is part of the Atlassian Corporation Amended and Restated 201...

This filing details a transaction by Jiang Tianyi, CEO of AvePoint, Inc. On December 19, 2025, Mr. Tianyi disposed of 4,706 shares of the company's common stock. The disposal was an exempt transaction to cover tax liabilities incurred upon the net settlement of restricted stock units (RSUs). The shares were withheld by...

This Form 4 filing details a transaction by Gong Xunkai, Executive Chairman and Director of AvePoint, Inc. (AVPT). On December 19, 2025, Mr. Xunkai disposed of 6,500 shares of the company's common stock. The transaction code 'F' indicates an exempt transaction related to the satisfaction of tax liabilities through the ...

Caci James, Chief Financial Officer of AvePoint, Inc., reported a disposition of 2823 shares of common stock on December 19, 2025. The shares were sold at a price of $13.94 per share. This transaction was part of a net settlement to cover tax liabilities related to equity incentives. Following this transaction, James h...

This filing details a transaction by Brian Michael Brown, Chief Legal Officer and Director of AvePoint, Inc. On December 19, 2025, Mr. Brown disposed of 1,547 shares of the company's common stock. The transaction code "F" indicates an exempt transaction related to the satisfaction of tax liabilities through the withhol...

Troy D. Weaver, President, Global Refinish at Axalta Coating Systems Ltd. (AXTA), reported transactions on December 22, 2025. Weaver acquired 11,006 Common Shares through the net settlement of an Employee Stock Option, with a conversion or exercise price of $23.24 per share. Following this, 9,346 shares were withheld t...

This filing details stock transactions by Aristotle N. Balogh, Chief Technology Officer of Airbnb, Inc., on December 19, 2025. Balogh disposed of 650 shares of Class A Common Stock at a weighted average price of $134.15, acquired 1915 shares at $122.41, and disposed of an additional 1915 shares at prices ranging from $...

This filing details transactions made by Kenneth Eugene Smith, a director at BAR HARBOR BANKSHARES, on December 19, 2025. The transactions involved the acquisition of Common Stock through the company's Dividend Reinvestment and Direct Stock Purchase and Sale Plan. Specifically, 12 shares were acquired at $33.36 each, f...

This filing details transactions made by Curtis C. Simard, President/CEO and Director of BAR HARBOR BANKSHARES. On December 19, 2025, Simard acquired 703.533 shares of Common Stock at $33.25 per share and an additional 46.6022 shares at $33.42 per share, both through the Bar Harbor Bankshares Dividend Reinvestment and ...

This filing details a transaction by Matthew L. Caras, a director at BAR HARBOR BANKSHARES (BHB). On December 19, 2025, Mr. Caras acquired 126.202 shares of Common Stock at a price of $33.25 per share, bringing his total ownership to 21998.707 shares. This acquisition was made through the company's Dividend Reinvestmen...

Colter David M, a director at BAR HARBOR BANKSHARES (BHB), acquired 14.9598 shares of common stock on December 19, 2025, through the company's Dividend Reinvestment and Direct Stock Purchase and Sale Plan. This transaction, exempt under Rule 16b-3(d), resulted in a post-transaction share count of 12187.2492 for Mr. Col...

On December 19, 2025, Shaw Brian D, a director at BAR HARBOR BANKSHARES (BHB), acquired 39.493 shares of Common Stock at a price of $33.25 per share. This transaction, made through the company's Dividend Reinvestment and Direct Stock Purchase and Sale Plan, resulted in a post-transaction holding of 18878.763 shares. Th...

Heather D. Jones, a director at BAR HARBOR BANKSHARES (BHB), acquired 23.995 shares of common stock on December 19, 2025, at a price of $33.25 per share. This transaction, exempt under Rule 16b-3(d), was made through the company's Dividend Reinvestment and Direct Stock Purchase and Sale Plan. Following this acquisition...

This filing details a transaction by Ashley B. Griffith, a director at BIMINI CAPITAL MANAGEMENT, INC. On December 19, 2025, Griffith acquired 50,000 shares of Class A Common Stock at a price of $1.55 per share. Following this transaction, Griffith directly owns 50,000 shares of the company's stock. The transaction cod...

G. Hunter Haas IV, Chief Financial Officer and 10% owner of BIMINI CAPITAL MANAGEMENT, INC. (BMNM), reported a transaction on December 19, 2025. Haas acquired 192,247 shares of Class A Common Stock at a price of $1.55 per share. Following this transaction, Haas directly owns 1,491,517 shares of Class A Common Stock. Th...

This filing details a transaction by Robert E. Cauley, CEO and 10% owner of BIMINI CAPITAL MANAGEMENT, INC. (BMNM). On December 19, 2025, Cauley acquired 192,248 shares of Class A Common Stock at a price of $1.55 per share. Following this acquisition, his total direct ownership of the company's Class A Common Stock inc...

Robert J. Dwyer, a 10% owner and director of BIMINI CAPITAL MANAGEMENT, INC. (BMNM), reported a transaction on December 19, 2025. Dwyer acquired 100,000 shares of Class A Common Stock at a price of $1.55 per share. Following this transaction, Dwyer directly owns 1,476,339 shares of the company's stock. The filing was s...

Charles K. Gayer, President and CCO of BioCryst Pharmaceuticals Inc (BCRX), filed a Form 4 reporting significant stock transactions between December 19-22, 2025. On December 19, Gayer disposed of 11,477 shares at $7.41 per share through tax withholding for vested restricted stock units. On December 22, he exercised thr...

This filing details transactions made by Alane P. Barnes, Chief Legal Officer of BIOCRYST PHARMACEUTICALS INC, on December 19, 2025, and December 22, 2025. On December 19, 2025, 16,902 shares of Common Stock were withheld to satisfy tax obligations related to the vesting of restricted stock units. This was a non-discre...